These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11164985

  • 21. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 27; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 23. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U, Paczek L, Mucha K, Foroncewicz B, Perkowska-Ptasińska A.
    Transplant Proc; 2006 Feb 27; 38(1):66-8. PubMed ID: 16504666
    [Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
    Reis A, Reinhard T, Voiculescu A, Kutkuhn B, Godehardt E, Spelsberg H, Althaus C, Sundmacher R.
    Br J Ophthalmol; 1999 Nov 27; 83(11):1268-71. PubMed ID: 10535855
    [Abstract] [Full Text] [Related]

  • 25. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.
    Schrama YC, Joles JA, van Tol A, Boer P, Koomans HA, Hené RJ.
    Transplantation; 2000 Feb 15; 69(3):376-83. PubMed ID: 10706046
    [Abstract] [Full Text] [Related]

  • 26. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
    Mourad M, Malaise J, Chaib Eddour D, De Meyer M, König J, Schepers R, Squifflet JP, Wallemacq P.
    Clin Chem; 2001 Jan 15; 47(1):88-94. PubMed ID: 11148182
    [Abstract] [Full Text] [Related]

  • 27. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I, Baryalei M, Busch T, Pieske B, Schorn B, Strauch J, Sîrbu H, Dalichau H.
    Transplantation; 2000 Apr 27; 69(8):1586-90. PubMed ID: 10836367
    [Abstract] [Full Text] [Related]

  • 28. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients.
    Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O'Connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS.
    Transplantation; 1993 Jul 27; 56(1):75-82. PubMed ID: 8333071
    [Abstract] [Full Text] [Related]

  • 29. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W.
    Transplantation; 2000 Jul 15; 70(1):143-8. PubMed ID: 10919591
    [Abstract] [Full Text] [Related]

  • 30. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.
    Cransberg K, Cornelissen M, Lilien M, Van Hoeck K, Davin JC, Nauta J.
    Transplantation; 2007 Apr 27; 83(8):1041-7. PubMed ID: 17452893
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.
    Bilodeau JF, Montambault P, Wolff JL, Lemire J, Masse M.
    Transplant Proc; 2009 Nov 27; 41(9):3683-9. PubMed ID: 19917367
    [Abstract] [Full Text] [Related]

  • 32. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.
    Transplantation; 2003 Jan 15; 75(1):54-9. PubMed ID: 12544871
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Lange S, Mueller SC, Altmann S, Dahlhaus M, Drewelow B, Freund M, Junghanss C.
    Bone Marrow Transplant; 2008 Apr 15; 41(7):667-74. PubMed ID: 18084333
    [Abstract] [Full Text] [Related]

  • 34. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.
    Clin Transplant; 1998 Jun 15; 12(3):198-205. PubMed ID: 9642510
    [Abstract] [Full Text] [Related]

  • 35. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.
    Abramowicz D, Manas D, Lao M, Vanrenterghem Y, Del Castillo D, Wijngaard P, Fung S, Cyclosporine Withdrawal Study Group.
    Transplantation; 2002 Dec 27; 74(12):1725-34. PubMed ID: 12499889
    [Abstract] [Full Text] [Related]

  • 36. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B, Ikonen T, Briffa N, Berry GJ, Christians U, Robbins RC, Hook L, Serkova N, Benet LZ, Schuler W, Morris RE.
    Transplantation; 2000 Jan 15; 69(1):76-86. PubMed ID: 10653384
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 39. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
    Birnbaum F, Böhringer D, Sokolovska Y, Sundmacher R, Reinhard T.
    Transplantation; 2005 Apr 27; 79(8):964-8. PubMed ID: 15849551
    [Abstract] [Full Text] [Related]

  • 40. Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs. mycophenolate mofetil as a switch agent using a primary steroid-free rapamune and microemulsion cyclosporine protocol.
    Pelletier RP, Soule J, Henry ML, Rajab A, Ferguson RM.
    Clin Transplant; 2007 Apr 27; 21(4):532-5. PubMed ID: 17645715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.